Established in 2000, Arsenal Capital Partners is a leading New York based private equity firm that specializes in control investments in Specialty Industrials and Healthcare businesses. Arsenal works with management teams to build strategically important companies with leading market positions, high growth, and high value-add. Since inception, Arsenal has raised institutional equity investment funds of approximately $3.0 billion.
Niche specialty chemicals and specialty materials sub-sectors with valuable technologies that can provide product and service differentiation. Arsenal seeks businesses that service end markets where it has deep experience and insights.
Outsourced business services companies that focus on biopharmaceutical research, development and commercialization, and business services to providers and payors. Arsenal seeks businesses that leverage information and technology to improve efficiency and reduce costs.
Arsenal Capital Partners is a specialized private equity firm that invests in the U.S. middle market with a narrow and deep focus in two sectors, Specialty Industrials and Healthcare. Our philosophy is to partner with talented management teams, provide them with access to world-class operating resources and patient capital, and develop positive, open and constructive relationships that foster long-term value creation.